Incretins GIP and GLP-1 in Diabetes and Obesity
800 million people worldwide struggle with obesity, a disease that will cost over $1 trillion in medical consequences by 2025. The CDC reports severe obesity leads to life-altering and often life-threatening conditions like heart disease, stroke, type 2 diabetes, and certain cancers.
What is the “Incretin Effect”?
To help understand the mechanisms behind obesity and to develop treatments, researchers study several hormones, including incretin hormones GIP and GLP-1. Learn more about the incretins, their well-published “incretin effect,” and their potential relationship to obesity by downloading our free article “The Role of Incretins GIP and GLP-1 in Diabetes and Obesity" on the right.
Incretins GIP and GLP-1 Article